Invention Grant
- Patent Title: Cationic polyphosphazene compound, polyphosphazenes-drug conjugate compound and method for preparing same
-
Application No.: US16430244Application Date: 2019-06-03
-
Publication No.: US10590243B2Publication Date: 2020-03-17
- Inventor: Youn Soo Sohn , Yong Joo Jun , Prakash Gouda Avaji
- Applicant: CNPHARM CO., LTD.
- Applicant Address: KR Seoul
- Assignee: CNPHARM CO., LTD.
- Current Assignee: CNPHARM CO., LTD.
- Current Assignee Address: KR Seoul
- Agency: Procopio, Cory, Hargreaves & Savitch LLP
- Priority: KR10-2014-0030564 20140314; KR10-2015-0034030 20150311
- Main IPC: C08G79/025
- IPC: C08G79/025 ; A61K47/58 ; A61K47/60 ; C08G81/00 ; A61K31/555 ; A61K31/4745 ; A61K31/337

Abstract:
The present invention relates to a new class of cationic linear polyphosphazenes bearing as side groups a hydrophilic poly(ethylene glycol) and a spacer group selected from the group consisting of lysine, oligopeptides containing lysine, amino-ethanol, amino-propanol, amino-butanol, amino-pentanol and amino-hexanol, and the polyphosphazene-drug conjugates comprising hydrophobic anticancer drugs by covalent bonding and the preparation methods thereof. The present polyphosphazene-drug conjugates exhibit outstanding tumor selectivity and low toxicity.
Public/Granted literature
Information query